SS

Sudeshna Saha

Active Director Director DIN 10256538
DIN 10256538 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Sudeshna Saha

Data last updated:

Sudeshna Saha is a Director at Ntree Biotech Private Limited (since 2023). The company operates in Paper. Ntree Biotech Private Limited reported revenue of ₹10.8 Lakh (FY 2025).

DIN 10256538
Primary Designation Director
Industry Paper
First Appointment 27 Jul 2023
Oldest Company Age 3 yrs
Largest company Ntree Biotech Private Limited · ₹10.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ntree Biotech Private Limited U21002WB2023PTC263849
Director27 Jul 20232023₹10.8 Lakh (FY 2025)Active

Board colleagues of Sudeshna Saha

NameDINCompanyDesignation
Nityananda Saha10256539Ntree Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ntree Biotech Private Limited
Premium access

Shareholding and investment profile for Sudeshna Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudeshna Saha

Sudeshna Saha currently holds 1 directorship: Ntree Biotech Private Limited (Director, since 27 Jul 2023, revenue ₹10.8 Lakh (FY 2025)).

Sudeshna Saha was first appointed on 27 Jul 2023 as Director at Ntree Biotech Private Limited.

The current boards of Sudeshna Saha's companies include Nityananda Saha (Ntree Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available